Central to our world without disease vision is the idea that, with rapid advances in technology and science, we are better positioned to disrupt disease processes earlier and maintain health and wellness for the long-term. Ben Wiegand, Global Head, World Without Disease Accelerator, shares how the Janssen Pharmaceutical Companies of Johnson & Johnson, Johnson & Johnson Innovation and public sector partners in Finland are collaborating with the world to create the “Baby Box of the future” to promote child health and detect childhood disease at an earlier time.

“Strength lies in difference, not in similarities,” wrote Steven Covey, author of The 7 Habits of Highly Effective People.

Johnson & Johnson has embraced this principle ever since its inception in 1886, when women made up more than half of the company’s initial 14 employees.

And 130 years later, an inclusive workforce underpinned by diverse perspectives remains critical to the success of our business and the wellbeing of our employees.

For more than three decades, Janssen Immunology has been focused on innovating for patients, because we understand the impact rheumatic diseases have on individuals, and their families, friends and loved ones. The pain and disability caused by diseases of the joints can impact life’s moments of more people than any other disease.

At Janssen Oncology, we envision a world where cancer is a preventable, chronic, or curable disease. To achieve victories over cancer, we’re focused on developing resources that are designed to help patients throughout their cancer journey.